| Reference |
Sentence |
Publish Date |
Extraction Date |
Species |
| Akihiro Hasumi, Hideyuki Maed. Cannabidiol improves haloperidol-induced motor dysfunction in zebrafish: a comparative study with a dopamine activating drug. Journal of cannabis research vol 5 issue 1 2023 36871008 |
cannabidiol improves haloperidol-induced motor dysfunction in zebrafish: a comparative study with a dopamine activating drug. |
2023-03-04 |
2023-03-06 |
rat |
| Roberto Frau, Miriam Meli. Sex-specific susceptibility to psychotic-like states provoked by prenatal THC exposure: Reversal by pregnenolone. Journal of neuroendocrinology vol issue 2023 36810840 |
moreover, we present how pregnenolone, a neurosteroid that showed beneficial properties on the effects elicited by cannabis intoxication, normalizes mesolimbic dopamine function and rescues psychotic-like phenotypes. |
2023-02-22 |
2023-03-06 |
Not clear |
| Lei Wang, Xinghong Wu, Ge Yang, Nan Hu, Zijian Zhao, Lei Zhao, Shengyu L. Cannabidiol alleviates the damage to dopaminergic neurons in MPTP-induced Parkinson's disease mice via regulating neuronal apoptosis and neuroinflammation. Neuroscience vol issue 2022 35792194 |
this study aimed to investigate the protective effect of cannabidiol (cbd) on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp)-induced neuronal dopamine injury by inhibiting neuroinflammation, which was one of the factors that cause neuronal apoptosis. |
2022-07-06 |
2023-01-27 |
mouse |
| Samuel F Acuff, Nicholas W Simon, James G Murph. Effort-related decision making and cannabis use among college students. Experimental and clinical psychopharmacology vol issue 2022 35084912 |
cannabis exerts an indirect effect on dopamine (da) output in the mesolimbic projection, a circuit implicated in reward processing and effort expenditure, and thus may be associated with aberrant effort-based decision making. |
2022-01-27 |
2023-01-27 |
Not clear |
| Baoyu Shen, Dongxian Zhang, Xiaofeng Zeng, Lina Guan, Genmeng Yang, Liu Liu, Jian Huang, Yuanyuan Li, Shijun Hong, Lihua L. Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway. Psychopharmacology vol issue 2022 34997862 |
cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the drd1-mecp2-bdnf-trkb signaling pathway. |
2022-01-08 |
2023-01-26 |
Not clear |
| Katina C Calakos, Heather Liu, Yihuan Lu, Jon Mikael Anderson, David Matuskey, Nabeel Nabulsi, Yunpeng Ye, Patrick D Skosnik, Deepak Cyril D'Souza, Evan D Morris, Kelly P Cosgrove, Ansel T Hillme. Assessment of transient dopamine responses to smoked cannabis. Drug and alcohol dependence vol 227 issue 2021 34399137 |
assessment of transient dopamine responses to smoked cannabis. |
2021-10-21 |
2023-01-26 |
Not clear |
| Kiana Nouri, Mahsa Anooshe, Saeideh Karimi-Haghighi, Zahra Mousavi, Abbas Haghparas. Involvement of Hippocampal D1-Like Dopamine Receptors in the Inhibitory Effect of Cannabidiol on Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference. Neurochemical research vol 46 issue 8 2021 33993443 |
involvement of hippocampal d1-like dopamine receptors in the inhibitory effect of cannabidiol on acquisition and expression of methamphetamine-induced conditioned place preference. |
2021-10-18 |
2023-01-26 |
rat |
| Amir Arash Hassanlou, Shole Jamali, Kimia RayatSanati, Zahra Mousavi, Abbas Haghparas. Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region. Brain research bulletin vol 172 issue 2021 33862125 |
cannabidiol modulates the meth-induced conditioned place preference through d2-like dopamine receptors in the hippocampal ca1 region. |
2021-10-07 |
2023-01-26 |
rat |
| Amir Arash Hassanlou, Shole Jamali, Kimia RayatSanati, Zahra Mousavi, Abbas Haghparas. Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region. Brain research bulletin vol 172 issue 2021 33862125 |
cannabidiol (cbd) has been shown to reduce the effects of meth through different mechanisms such as increasing the ecs activity, regulating emotional memory in the ventral hippocampus through d2-like dopamine receptors, and decreasing the mesolimbic dopaminergic activity. |
2021-10-07 |
2023-01-26 |
rat |
| Amir Arash Hassanlou, Shole Jamali, Kimia RayatSanati, Zahra Mousavi, Abbas Haghparas. Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region. Brain research bulletin vol 172 issue 2021 33862125 |
the present study tried to find out the role of hippocampal ca1 d2-like dopamine receptors (d2r) in the effects of cannabidiol on the acquisition and expression of meth-induced conditioned place preference (meth-cpp) in rats by using microinjection of sulpiride as a d2r antagonist. |
2021-10-07 |
2023-01-26 |
rat |
| Anna Brancato, Valentina Castelli, Gianluca Lavanco, Giuseppe Tringali, Vincenzo Micale, Martin Kuchar, Cesare D'Amico, Giuseppe Pizzolanti, Salvatore Feo, Carla Cannizzar. Binge-like Alcohol Exposure in Adolescence: Behavioural, Neuroendocrine and Molecular Evidence of Abnormal Neuroplasticity\\xe2\\x80\\xa6 and Return. Biomedicines vol 9 issue 9 2021 34572345 |
notably, subchronic cannabidiol, during withdrawal, attenuates social- and novelty-induced aversion and passive stress-coping and rectifies the hyper-responsive stress axis and nac dopamine and glutamate-related neuroplasticity. |
2021-10-01 |
2023-01-26 |
rat |
| Ludovic Polli, Raymund Schwan, Eliane Albuisson, Laura Malbos, Karine Angioi-Duprez, Vincent Laprevote, Thomas Schwitze. Oscillatory potentials abnormalities in regular cannabis users: Amacrine cells dysfunction as a marker of central dopaminergic modulation. Progress in neuro-psychopharmacology & biological psychiatry vol 108 issue 2021 32860840 |
regular cannabis use induces a decreased capacity for dopamine synthesis in the brain. |
2021-09-02 |
2023-01-26 |
Not clear |
| J G Ramaekers, N L Mason, E L Theunisse. Blunted highs: Pharmacodynamic and behavioral models of cannabis tolerance. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology vol 36 issue 2021 32014378 |
such neuroadaptions are absent in occasional users, who show strong increments of dopamine and glutamate levels in the striatum, a loss of functional connectivity within the mesolimbic circuit and neurocognitive impairments when exposed to cannabis. |
2021-08-10 |
2023-01-26 |
human |
| Christin Schifani, Jens Pruessner, Huai-Hsuan Tseng, Naren Rao, Abanti Tagore, Alan A Wilson, Sylvain Houle, Pablo M Rusjan, Romina Mizrah. Stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis. Addiction biology vol 25 issue 4 2021 31389139 |
we have previously shown that subjects at clinical high risk for psychosis (chr) exhibit a higher striatal dopamine response to stress compared with healthy volunteers (hv), with chronic cannabis use blunting this response. |
2021-06-28 |
2023-01-26 |
human |
| Christin Schifani, Jens Pruessner, Huai-Hsuan Tseng, Naren Rao, Abanti Tagore, Alan A Wilson, Sylvain Houle, Pablo M Rusjan, Romina Mizrah. Stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis. Addiction biology vol 25 issue 4 2021 31389139 |
stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis. |
2021-06-28 |
2023-01-26 |
human |
| Kenneth Blum, Joseph Morgan, Jean Lud Cadet, David Baron, Paul R Carney, Jag Khalsa, Rajendra D Badgaiyan, Mark S Gol. Psychoactive Drugs Like Cannabis -Induce Hypodopaminergic Anhedonia and Neuropsychological Dysfunction in Humans: Putative Induction of Dopamine Homeostasis via Coupling of Genetic Addiction Risk Severity (GARS) testing and Precision Pro-dopamine Regulation (KB220). Neurology (E-Cronicon) vol 13 issue 4 2021 34085060 |
psychoactive drugs like cannabis -induce hypodopaminergic anhedonia and neuropsychological dysfunction in humans: putative induction of dopamine homeostasis via coupling of genetic addiction risk severity (gars) testing and precision pro-dopamine regulation (kb220). |
2021-06-06 |
2023-01-26 |
Not clear |
| Anna Grzywacz, Wojciech Barczak, Jolanta Chmielowiec, Krzysztof Chmielowiec, Aleksandra Suchanecka, Grzegorz Trybek, Jolanta Masiak, Pawe\\xc5\\x82 Jagielski, Katarzyna Grocholewicz, Blazej Rubi\\xc5\\x9. Contribution of Dopamine Transporter Gene Methylation Status to Cannabis Dependency. Brain sciences vol 10 issue 6 2021 32586035 |
contribution of dopamine transporter gene methylation status to cannabis dependency. |
2021-06-04 |
2023-01-26 |
Not clear |
| Hye Bin Yoo, Jennifer DiMuzio, Francesca M Filbe. Interaction of Cannabis Use and Aging: From Molecule to Mind. Journal of dual diagnosis vol 16 issue 1 2021 31570066 |
specifically, the effects of cannabis and aging converge on overlapping networks in the endocannabinoid, opioid, and dopamine systems that may affect functional decline particularly in the hippocampus and prefrontal cortex, which are critical areas for memory and executive functioning. |
2021-05-21 |
2023-01-26 |
Not clear |
| Marco Colizzi, Nathalie Weltens, Philip McGuire, David Lythgoe, Steve Williams, Lukas Van Oudenhove, Sagnik Bhattacharyy. Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis. Molecular psychiatry vol 25 issue 12 2021 30770892 |
while some evidence suggests altered striatal dopamine may underlie the association, direct evidence that cannabis use affects either acute or chronic striatal dopamine is inconclusive. |
2021-05-14 |
2023-01-26 |
human |
| Marco Colizzi, Nathalie Weltens, Philip McGuire, David Lythgoe, Steve Williams, Lukas Van Oudenhove, Sagnik Bhattacharyy. Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis. Molecular psychiatry vol 25 issue 12 2021 30770892 |
in contrast, pre-clinical research suggests that cannabis may affect dopamine via modulation of glutamate signaling. |
2021-05-14 |
2023-01-26 |
human |